The purpose was to increase funding for malaria research in the Department of Defense.
2026 · 2nd Quarter (Apr 1 - June 30)
MMV MEDICINES FOR MALARIA VENTURE
Filed by CORNERSTONE GOVERNMENT AFFAIRS, INC..
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 10, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- CORNERSTONE GOVERNMENT AFFAIRS, INC.
- Filing UUID
- 1afe123c-1a82-4d6c-9320-6d3b7fc6126c
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
The purpose was to increase funding for malaria research in the Department of Defense.
The purpose was to increase funding for malaria research in the Department of Defense.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.